Free Trial

Evolent Health (EVH) Competitors

Evolent Health logo
$10.97 +0.10 (+0.92%)
(As of 11:39 AM ET)

EVH vs. NVEI, TNET, CARG, DXC, ALIT, CLVT, PAYO, RNG, DLO, and ACVA

Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Nuvei (NVEI), TriNet Group (TNET), CarGurus (CARG), DXC Technology (DXC), Alight (ALIT), Clarivate (CLVT), Payoneer Global (PAYO), RingCentral (RNG), DLocal (DLO), and ACV Auctions (ACVA). These companies are all part of the "business services" industry.

Evolent Health vs.

Nuvei (NASDAQ:NVEI) and Evolent Health (NYSE:EVH) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Nuvei presently has a consensus target price of $32.08, indicating a potential downside of 5.63%. Evolent Health has a consensus target price of $26.18, indicating a potential upside of 140.86%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts plainly believe Evolent Health is more favorable than Nuvei.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuvei
0 Sell rating(s)
9 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.40
Evolent Health
0 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.00

Nuvei has a beta of 2.51, meaning that its share price is 151% more volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.

42.5% of Nuvei shares are held by institutional investors. 20.0% of Nuvei shares are held by company insiders. Comparatively, 1.6% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nuvei has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Nuvei, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuvei$1.19B4.05-$7.84M$0.15226.60
Evolent Health$2.46B0.51-$113.04M-$0.91-11.95

Evolent Health received 505 more outperform votes than Nuvei when rated by MarketBeat users. Likewise, 74.37% of users gave Evolent Health an outperform vote while only 57.29% of users gave Nuvei an outperform vote.

CompanyUnderperformOutperform
NuveiOutperform Votes
55
57.29%
Underperform Votes
41
42.71%
Evolent HealthOutperform Votes
560
74.37%
Underperform Votes
193
25.63%

Nuvei has a net margin of 1.75% compared to Evolent Health's net margin of -2.93%. Nuvei's return on equity of 7.40% beat Evolent Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Nuvei1.75% 7.40% 2.92%
Evolent Health -2.93%6.30%2.57%

In the previous week, Nuvei and Nuvei both had 2 articles in the media. Nuvei's average media sentiment score of 0.50 beat Evolent Health's score of -0.64 indicating that Nuvei is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nuvei
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evolent Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Summary

Nuvei beats Evolent Health on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVH vs. The Competition

MetricEvolent HealthManagement services IndustryComputer SectorNYSE Exchange
Market Cap$1.27B$6.72B$24.71B$19.67B
Dividend YieldN/A3.40%2.70%3.51%
P/E Ratio-11.9412.30276.5543.78
Price / Sales0.512.102,926.5017.61
Price / Cash6.6915.5933.8021.73
Price / Book1.1611.767.835.46
Net Income-$113.04M$136.01M$659.53M$987.68M
7 Day Performance-8.96%-2.47%-0.18%-2.32%
1 Month Performance-11.95%-3.68%9.95%0.63%
1 Year Performance-64.58%-7.61%25.54%16.39%

Evolent Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVH
Evolent Health
2.7273 of 5 stars
$10.97
+0.9%
$26.18
+138.7%
-64.2%$1.28B$2.46B-12.054,700
NVEI
Nuvei
1.7451 of 5 stars
$33.99
+0.0%
$32.08
-5.6%
+42.6%$4.82B$1.19B226.602,202News Coverage
Positive News
High Trading Volume
TNET
TriNet Group
4.6245 of 5 stars
$95.02
-0.4%
$117.00
+23.1%
-24.5%$4.71B$4.97B18.313,600Dividend Announcement
Positive News
CARG
CarGurus
3.7389 of 5 stars
$38.21
+1.4%
$37.86
-0.9%
+56.8%$3.96B$914.24M-81.891,343Analyst Forecast
Positive News
DXC
DXC Technology
2.963 of 5 stars
$21.40
-0.3%
$20.89
-2.4%
-13.9%$3.87B$13.67B268.28130,000Short Interest ↓
ALIT
Alight
3.4896 of 5 stars
$7.09
-1.0%
$10.83
+52.8%
-14.0%$3.85B$3.41B-14.9218,000
CLVT
Clarivate
2.964 of 5 stars
$5.39
+5.5%
$7.10
+31.7%
-35.8%$3.83B$2.58B-2.7612,000Buyback Announcement
PAYO
Payoneer Global
4.2463 of 5 stars
$10.46
+1.8%
$11.36
+8.6%
+114.0%$3.73B$940.30M29.372,167
RNG
RingCentral
3.9421 of 5 stars
$39.88
+2.1%
$41.43
+3.9%
+16.6%$3.61B$2.36B-36.844,084Analyst Forecast
DLO
DLocal
2.4809 of 5 stars
$11.92
+1.6%
$12.61
+5.8%
-26.2%$3.53B$729.49M29.33540
ACVA
ACV Auctions
3.1799 of 5 stars
$20.80
+2.5%
$23.60
+13.5%
+45.0%$3.49B$596.02M-43.192,170Analyst Forecast
Short Interest ↓
Positive News

Related Companies and Tools


This page (NYSE:EVH) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners